ID HAOX1_MOUSE Reviewed; 370 AA. AC Q9WU19; DT 21-FEB-2001, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1999, sequence version 1. DT 27-MAR-2024, entry version 163. DE RecName: Full=2-Hydroxyacid oxidase 1 {ECO:0000305|PubMed:9891009}; DE Short=HAOX1; DE EC=1.1.3.15 {ECO:0000305|PubMed:9891009}; DE AltName: Full=Glycolate oxidase {ECO:0000303|PubMed:9891009}; DE Short=GOX {ECO:0000303|PubMed:9891009}; DE AltName: Full=Glyoxylate oxidase {ECO:0000250|UniProtKB:Q9UJM8}; DE EC=1.2.3.5 {ECO:0000250|UniProtKB:Q9UJM8}; GN Name=Hao1 {ECO:0000312|MGI:MGI:96011}; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, PATHWAY, AND RP TISSUE SPECIFICITY. RC TISSUE=Liver; RX PubMed=9891009; DOI=10.1074/jbc.274.4.2401; RA Kohler S.A., Menotti E., Kuhn L.C.; RT "Molecular cloning of mouse glycolate oxidase. High evolutionary RT conservation and presence of an iron-responsive element-like sequence in RT the mRNA."; RL J. Biol. Chem. 274:2401-2407(1999). RN [2] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-194, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=17242355; DOI=10.1073/pnas.0609836104; RA Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.; RT "Large-scale phosphorylation analysis of mouse liver."; RL Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007). RN [3] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-194, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [4] RP SUCCINYLATION [LARGE SCALE ANALYSIS] AT LYS-184, AND IDENTIFICATION BY MASS RP SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001; RA Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y., RA Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.; RT "SIRT5-mediated lysine desuccinylation impacts diverse metabolic RT pathways."; RL Mol. Cell 50:919-930(2013). CC -!- FUNCTION: Broad substrate specificity (S)-2-hydroxy-acid oxidase that CC preferentially oxidizes glycolate (PubMed:9891009). The glyoxylate CC produced by the oxidation of glycolate can then be utilized by alanine- CC glyoxylate aminotransferase for the peroxisomal synthesis of glycine; CC this pathway appears to be an important step for the detoxification of CC glyoxylate which, if allowed to accumulate, may be metabolized to CC oxalate with formation of kidney stones (By similarity). Can also CC catalyze the oxidation glyoxylate, and long chain hydroxyacids such as CC 2-hydroxyhexadecanoate and 2-hydroxyoctanoate (By similarity). Active CC in vitro with the artificial electron acceptor 2,6- CC dichlorophenolindophenol (DCIP), but O2 is believed to be the CC physiological electron acceptor, leading to the production of H2O2 CC (PubMed:9891009). {ECO:0000250|UniProtKB:Q9UJM8, CC ECO:0000269|PubMed:9891009}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a (2S)-2-hydroxycarboxylate + O2 = a 2-oxocarboxylate + H2O2; CC Xref=Rhea:RHEA:16789, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, CC ChEBI:CHEBI:35179, ChEBI:CHEBI:58123; EC=1.1.3.15; CC Evidence={ECO:0000305|PubMed:9891009}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16790; CC Evidence={ECO:0000305|PubMed:9891009}; CC -!- CATALYTIC ACTIVITY: CC Reaction=glycolate + O2 = glyoxylate + H2O2; Xref=Rhea:RHEA:25311, CC ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:29805, CC ChEBI:CHEBI:36655; EC=1.1.3.15; CC Evidence={ECO:0000305|PubMed:9891009}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:25312; CC Evidence={ECO:0000305|PubMed:9891009}; CC -!- CATALYTIC ACTIVITY: CC Reaction=glyoxylate + H2O + O2 = H(+) + H2O2 + oxalate; CC Xref=Rhea:RHEA:14837, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, ChEBI:CHEBI:30623, CC ChEBI:CHEBI:36655; EC=1.2.3.5; CC Evidence={ECO:0000250|UniProtKB:Q9UJM8}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14838; CC Evidence={ECO:0000250|UniProtKB:Q9UJM8}; CC -!- CATALYTIC ACTIVITY: CC Reaction=2-hydroxyhexadecanoate + O2 = 2-oxohexadecanoate + H2O2; CC Xref=Rhea:RHEA:67944, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, CC ChEBI:CHEBI:65097, ChEBI:CHEBI:176593; CC Evidence={ECO:0000250|UniProtKB:Q9UJM8}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67945; CC Evidence={ECO:0000250|UniProtKB:Q9UJM8}; CC -!- CATALYTIC ACTIVITY: CC Reaction=2-hydroxyoctanoate + O2 = 2-oxooctanoate + H2O2; CC Xref=Rhea:RHEA:67940, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240, CC ChEBI:CHEBI:133514, ChEBI:CHEBI:176689; CC Evidence={ECO:0000250|UniProtKB:Q9UJM8}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:67941; CC Evidence={ECO:0000250|UniProtKB:Q9UJM8}; CC -!- COFACTOR: CC Name=FMN; Xref=ChEBI:CHEBI:58210; CC Evidence={ECO:0000250|UniProtKB:Q9UJM8}; CC -!- PATHWAY: Amino-acid biosynthesis; glycine biosynthesis. CC {ECO:0000250|UniProtKB:Q9UJM8}. CC -!- SUBUNIT: Homotetramer. {ECO:0000250|UniProtKB:Q9UJM8}. CC -!- SUBCELLULAR LOCATION: Peroxisome matrix {ECO:0000250|UniProtKB:Q9UJM8}. CC -!- TISSUE SPECIFICITY: Liver. {ECO:0000269|PubMed:9891009}. CC -!- SIMILARITY: Belongs to the FMN-dependent alpha-hydroxy acid CC dehydrogenase family. {ECO:0000255|PROSITE-ProRule:PRU00683}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF104312; AAD25332.1; -; mRNA. DR CCDS; CCDS16783.1; -. DR RefSeq; NP_034533.1; NM_010403.2. DR AlphaFoldDB; Q9WU19; -. DR SMR; Q9WU19; -. DR BioGRID; 200206; 2. DR STRING; 10090.ENSMUSP00000028704; -. DR BindingDB; Q9WU19; -. DR ChEMBL; CHEMBL4295985; -. DR iPTMnet; Q9WU19; -. DR PhosphoSitePlus; Q9WU19; -. DR SwissPalm; Q9WU19; -. DR jPOST; Q9WU19; -. DR MaxQB; Q9WU19; -. DR PaxDb; 10090-ENSMUSP00000028704; -. DR ProteomicsDB; 269712; -. DR Antibodypedia; 8448; 480 antibodies from 32 providers. DR DNASU; 15112; -. DR Ensembl; ENSMUST00000028704.3; ENSMUSP00000028704.3; ENSMUSG00000027261.3. DR GeneID; 15112; -. DR KEGG; mmu:15112; -. DR UCSC; uc008mns.1; mouse. DR AGR; MGI:96011; -. DR CTD; 54363; -. DR MGI; MGI:96011; Hao1. DR VEuPathDB; HostDB:ENSMUSG00000027261; -. DR eggNOG; KOG0538; Eukaryota. DR GeneTree; ENSGT00390000018717; -. DR HOGENOM; CLU_020639_6_1_1; -. DR InParanoid; Q9WU19; -. DR OMA; RIWFRPK; -. DR OrthoDB; 276514at2759; -. DR PhylomeDB; Q9WU19; -. DR TreeFam; TF313363; -. DR BRENDA; 1.1.3.15; 3474. DR Reactome; R-MMU-389661; Glyoxylate metabolism and glycine degradation. DR Reactome; R-MMU-9033241; Peroxisomal protein import. DR UniPathway; UPA00288; -. DR BioGRID-ORCS; 15112; 2 hits in 78 CRISPR screens. DR ChiTaRS; Hao1; mouse. DR PRO; PR:Q9WU19; -. DR Proteomes; UP000000589; Chromosome 2. DR RNAct; Q9WU19; Protein. DR Bgee; ENSMUSG00000027261; Expressed in left lobe of liver and 16 other cell types or tissues. DR ExpressionAtlas; Q9WU19; baseline and differential. DR GO; GO:0043231; C:intracellular membrane-bounded organelle; ISO:MGI. DR GO; GO:0005782; C:peroxisomal matrix; ISO:MGI. DR GO; GO:0005777; C:peroxisome; IDA:HGNC-UCL. DR GO; GO:0003973; F:(S)-2-hydroxy-acid oxidase activity; IDA:MGI. DR GO; GO:0010181; F:FMN binding; ISS:UniProtKB. DR GO; GO:0047969; F:glyoxylate oxidase activity; ISO:MGI. DR GO; GO:0001561; P:fatty acid alpha-oxidation; ISS:UniProtKB. DR GO; GO:0006545; P:glycine biosynthetic process; IEA:UniProtKB-UniPathway. DR GO; GO:0046296; P:glycolate catabolic process; ISS:UniProtKB. DR GO; GO:0006979; P:response to oxidative stress; IEA:Ensembl. DR CDD; cd02809; alpha_hydroxyacid_oxid_FMN; 1. DR Gene3D; 3.20.20.70; Aldolase class I; 1. DR InterPro; IPR013785; Aldolase_TIM. DR InterPro; IPR012133; Alpha-hydoxy_acid_DH_FMN. DR InterPro; IPR000262; FMN-dep_DH. DR InterPro; IPR037396; FMN_HAD. DR InterPro; IPR008259; FMN_hydac_DH_AS. DR PANTHER; PTHR10578:SF137; 2-HYDROXYACID OXIDASE 1; 1. DR PANTHER; PTHR10578; S -2-HYDROXY-ACID OXIDASE-RELATED; 1. DR Pfam; PF01070; FMN_dh; 1. DR PIRSF; PIRSF000138; Al-hdrx_acd_dh; 1. DR SUPFAM; SSF51395; FMN-linked oxidoreductases; 1. DR PROSITE; PS00557; FMN_HYDROXY_ACID_DH_1; 1. DR PROSITE; PS51349; FMN_HYDROXY_ACID_DH_2; 1. DR Genevisible; Q9WU19; MM. PE 1: Evidence at protein level; KW Amino-acid biosynthesis; Flavoprotein; FMN; Oxidoreductase; Peroxisome; KW Phosphoprotein; Reference proteome. FT CHAIN 1..370 FT /note="2-Hydroxyacid oxidase 1" FT /id="PRO_0000206319" FT DOMAIN 1..365 FT /note="FMN hydroxy acid dehydrogenase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00683" FT MOTIF 368..370 FT /note="Microbody targeting signal" FT /evidence="ECO:0000255" FT ACT_SITE 260 FT /note="Proton acceptor" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00683" FT BINDING 26 FT /ligand="glyoxylate" FT /ligand_id="ChEBI:CHEBI:36655" FT /evidence="ECO:0000250|UniProtKB:Q9UJM8" FT BINDING 79..81 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:Q9UJM8" FT BINDING 108 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:Q9UJM8" FT BINDING 130 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:Q9UJM8" FT BINDING 132 FT /ligand="glyoxylate" FT /ligand_id="ChEBI:CHEBI:36655" FT /evidence="ECO:0000250|UniProtKB:Q9UJM8" FT BINDING 158 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:Q9UJM8" FT BINDING 167 FT /ligand="glyoxylate" FT /ligand_id="ChEBI:CHEBI:36655" FT /evidence="ECO:0000250|UniProtKB:Q9UJM8" FT BINDING 236 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:Q9UJM8" FT BINDING 258 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:Q9UJM8" FT BINDING 260 FT /ligand="glyoxylate" FT /ligand_id="ChEBI:CHEBI:36655" FT /evidence="ECO:0000250|UniProtKB:Q9UJM8" FT BINDING 263 FT /ligand="glyoxylate" FT /ligand_id="ChEBI:CHEBI:36655" FT /evidence="ECO:0000250|UniProtKB:Q9UJM8" FT BINDING 291..295 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:Q9UJM8" FT BINDING 314..315 FT /ligand="FMN" FT /ligand_id="ChEBI:CHEBI:58210" FT /evidence="ECO:0000250|UniProtKB:Q9UJM8" FT MOD_RES 184 FT /note="N6-succinyllysine" FT /evidence="ECO:0007744|PubMed:23806337" FT MOD_RES 194 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:17242355, FT ECO:0007744|PubMed:21183079" FT MOD_RES 230 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:Q9UJM8" SQ SEQUENCE 370 AA; 41001 MW; 97339211AF9FC19C CRC64; MLPRLVCISD YEQHVRSVLQ KSVYDYYRSG ANDQETLADN IQAFSRWKLY PRMLRNVADI DLSTSVLGQR VSMPICVGAT AMQCMAHVDG ELATVRACQT MGTGMMLSSW ATSSIEEVAE AGPEALRWMQ LYIYKDREIS RQIVKRAEKQ GYKAIFVTVD TPYLGNRIDD VRNRFKLPPQ LRMKNFETND LAFSPKGNFG DNSGLAEYVA QAIDPSLSWD DITWLRRLTS LPIVVKGILR GDDAKEAVKH GVDGILVSNH GARQLDGVPA TIDVLPEIVE AVEGKVEVFL DGGVRKGTDV LKALALGAKA VFVGRPIIWG LAFQGEKGVQ DVLEILKEEF RLAMALSGCQ NVKVIDKTLV RKNPLAVSKI //